Key result
This review highlights recent advances in platelet proteomics, emphasizing the potential of targeted quantification methods for identifying novel biomarkers and antiplatelet therapeutic targets.
Why the study?
Recent advances in proteomics have provided insights into platelet biology and responses across pathophysiological pathways, creating opportunities to characterize platelet functions, identify biomarkers, and uncover novel therapeutic targets.
Design
Review
Authors
Loading...
Advances in platelet proteomics merit prospective validation; leaves open their role in guiding antiplatelet therapy.
This review highlights the potential of quantitative platelet proteomics for identifying novel biomarkers and antiplatelet therapeutic targets.
Gianazza et al. (2020) conducted a review in Platelet biology in health and disease. This review highlights recent advances in platelet proteomics, emphasizing the potential of targeted quantification methods for identifying novel biomarkers and antiplatelet therapeutic targets.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: